Lataa...
Metrics for antibody therapeutics development
A wide variety of full-size monoclonal antibodies (mAbs) and therapeutics derived from alternative antibody formats can be produced through genetic and biological engineering techniques. These molecules are now filling the preclinical and clinical pipelines of every major pharmaceutical company and...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3011223/ https://ncbi.nlm.nih.gov/pubmed/20930555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.2.6.13603 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|